226 related articles for article (PubMed ID: 27157410)
1. The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers.
Shaker ME; Trawick BN; Mehal WZ
Biochem Pharmacol; 2016 Jul; 112():90-101. PubMed ID: 27157410
[TBL] [Abstract][Full Text] [Related]
2. Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice.
Yang HJ; Tang LM; Zhou XJ; Qian J; Zhu J; Lu L; Wang XH
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):619-25. PubMed ID: 26663010
[TBL] [Abstract][Full Text] [Related]
3. Intereukin-10 and Kupffer cells protect steatotic mice livers from ischemia-reperfusion injury.
Sutter AG; Palanisamy AP; Ellet JD; Schmidt MG; Schnellmann RG; Chavin KD
Eur Cytokine Netw; 2014; 25(4):69-76. PubMed ID: 25679269
[TBL] [Abstract][Full Text] [Related]
4. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver.
Kuroda S; Tashiro H; Igarashi Y; Tanimoto Y; Nambu J; Oshita A; Kobayashi T; Amano H; Tanaka Y; Ohdan H
J Hepatol; 2012 Jan; 56(1):146-52. PubMed ID: 21756846
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.
Ellett JD; Evans ZP; Atkinson C; Schmidt MG; Schnellmann RG; Chavin KD
Liver Transpl; 2009 Sep; 15(9):1101-9. PubMed ID: 19718644
[TBL] [Abstract][Full Text] [Related]
6. Chemical composition of hepatic lipids mediates reperfusion injury of the macrosteatotic mouse liver through thromboxane A(2).
El-Badry AM; Jang JH; Elsherbiny A; Contaldo C; Tian Y; Raptis DA; Laczko E; Moritz W; Graf R; Clavien PA
J Hepatol; 2011 Dec; 55(6):1291-9. PubMed ID: 21703192
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.
Bamboat ZM; Balachandran VP; Ocuin LM; Obaid H; Plitas G; DeMatteo RP
Hepatology; 2010 Feb; 51(2):621-32. PubMed ID: 19902481
[TBL] [Abstract][Full Text] [Related]
8. Decoy receptor 3 analogous supplement protects steatotic rat liver from ischemia-reperfusion injury.
Li TH; Liu CW; Lee PC; Huang CC; Lee KC; Hsieh YC; Yang YY; Hsieh SL; Lin HC; Tsai CY
J Chin Med Assoc; 2017 Jul; 80(7):391-400. PubMed ID: 28325574
[TBL] [Abstract][Full Text] [Related]
9. Ischemic preconditioning attenuates ischemia/reperfusion injury in rat steatotic liver: role of heme oxygenase-1-mediated autophagy.
Liu A; Guo E; Yang J; Li R; Yang Y; Liu S; Hu J; Jiang X; Dirsch O; Dahmen U; Sun J; Ouyang M
Oncotarget; 2016 Nov; 7(48):78372-78386. PubMed ID: 27852058
[TBL] [Abstract][Full Text] [Related]
10. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet.
Nakano H; Nagasaki H; Barama A; Boudjema K; Jaeck D; Kumada K; Tatsuno M; Baek Y; Kitamura N; Suzuki T; Yamaguchi M
Hepatology; 1997 Sep; 26(3):670-8. PubMed ID: 9303498
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin as additive of HTK preservation solution in cold ischemia/reperfusion injury of steatotic livers.
Eipel C; Hübschmann U; Abshagen K; Wagner KF; Menger MD; Vollmar B
J Surg Res; 2012 Mar; 173(1):171-9. PubMed ID: 21074785
[TBL] [Abstract][Full Text] [Related]
12. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
Llacuna L; Fernández A; Montfort CV; Matías N; Martínez L; Caballero F; Rimola A; Elena M; Morales A; Fernández-Checa JC; García-Ruiz C
J Hepatol; 2011 May; 54(5):1002-10. PubMed ID: 21145825
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion.
Massip-Salcedo M; Zaouali MA; Padrissa-Altés S; Casillas-Ramirez A; Rodés J; Roselló-Catafau J; Peralta C
Hepatology; 2008 Feb; 47(2):461-72. PubMed ID: 18098300
[TBL] [Abstract][Full Text] [Related]
14. mTOR activation protects liver from ischemia/reperfusion-induced injury through NF-κB pathway.
Li Z; Zhang J; Mulholland M; Zhang W
FASEB J; 2017 Jul; 31(7):3018-3026. PubMed ID: 28356345
[TBL] [Abstract][Full Text] [Related]
15. Loss of L-selectin-guided CD8
Kolachala VL; Palle S; Shen M; Feng A; Shayakhmetov D; Gupta NA
Hepatology; 2017 Oct; 66(4):1258-1274. PubMed ID: 28543181
[TBL] [Abstract][Full Text] [Related]
16. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion.
Serafín A; Roselló-Catafau J; Prats N; Gelpí E; Rodés J; Peralta C
Hepatology; 2004 Mar; 39(3):688-98. PubMed ID: 14999687
[TBL] [Abstract][Full Text] [Related]
17. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids.
El-Badry AM; Moritz W; Contaldo C; Tian Y; Graf R; Clavien PA
Hepatology; 2007 Apr; 45(4):855-63. PubMed ID: 17393510
[TBL] [Abstract][Full Text] [Related]
18. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.
Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ
Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115
[TBL] [Abstract][Full Text] [Related]
19. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury.
Casillas-Ramirez A; Amine-Zaouali M; Massip-Salcedo M; Padrissa-Altés S; Bintanel-Morcillo M; Ramalho F; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
Crit Care Med; 2008 Apr; 36(4):1256-66. PubMed ID: 18379253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
